As India Lifts its Vaccine Export Ban – will 600 Million India-made Doses of J&J Vaccine be Shipped to Rich Western Countries? 24/09/2021 Vidya Kirshnan In the coming months, 600 million doses of single-shot Johnson & Johnson vaccines, manufactured in Hyderabad, are likely to be exported to Europe or the United States, at a time when India grapples with vaccinating its own citizens. Civil-society organisations are concerned that millions of doses of the COVID-19 vaccine may end up in the […] Continue reading -> REGEN-COV Joins COVID-19 Treatment List; WHO and MSF Call for Lower Prices and Increased Access 24/09/2021 Raisa Santos REGEN-COV, the antibody cocktail made famous by Donald Trump when he became ill with COVID in 2020, was added Friday to WHO’s list of recommended drug treatments in updated COVID-19 clinical management guidelines, published Friday. At the same time, WHO and Médecins Sans Frontières/Doctors Without Borders (MSF) called on the US pharma firm Regeneron, which […] Continue reading -> World Leaders Call on Future German Chancellor to Support TRIPS Waiver 15/09/2021 Kerry Cullinan More than 140 former heads of state and Nobel laureates have called on the three candidates in line to be the next German chancellor to declare themselves in favour of waiving intellectual property on COVID-19 vaccines and transferring vaccine technologies. Germany is leading the European Commission’s refusal to accept the so-called TRIPS waiver proposal put […] Continue reading -> ‘High Hopes’ of WTO Action to Curb Harmful Fisheries Subsidies & Stimulate Pandemic Response – But Decisions Punted to Autumn 27/07/2021 Elaine Ruth Fletcher World Trade Organization Director General Ngozi Okonjo-Iweala has ” high hopes” that the WTO Ministerial Conference (MC12) that convenes at the end of November can deliver decisions that curb harmful fisheries subsidies as well as improving access of low- and middle-income countries to COVID medicines and vaccines. But WTO members must overcome a series of […] Continue reading -> Access Advocates Urge 11th Hour WTO Action on COVID IP Waiver – COVAX Strikes World Bank Deal on Vaccine Finance 26/07/2021 Elaine Ruth Fletcher Vaccine access advocates issued increasingly desperate, last minute calls upon the World Trade Organization to take action over a stalled initiative to impose a temporary waiver on intellectual property for COVID medicines, tests and vaccines – even as the initiative appeared doomed to a stalemate for the rest of the summer. Ahead of the opening […] Continue reading -> China Has Failed to Share ‘Raw Data’ About Virus Origin so Lab Accident Can’t be Ruled Out, Says Tedros 15/07/2021 Kerry Cullinan China came under renewed pressure from the World Health Organization (WHO) and Germany on Thursday to share data it has so far withheld in order to help determine the origin of the SARS-CoV2 virus that has cost over four million lives. Conceding that China had not shared all the data that the WHO virus origins […] Continue reading -> Roche Suspends Patents on Tocilizumab in LMICs After WHO Recommends it as Treatment for Severe COVID-19 08/07/2021 Kerry Cullinan Swiss pharmaceutical company Roche has suspended its patent rights on the medication tocilizumab in low- and middle-income countries (LMICs) for the duration of the pandemic, the company announced Tuesday. This follows the World Health Organization (WHO) recommendation on Monday for interleukin-6 (IL-6) receptor blockers to be given to patients hospitalised with severe or critical […] Continue reading -> Finally, Therapeutics for Severe COVID-19 – But They Come With Hefty Price Tags 06/07/2021 Kerry Cullinan After months with virtually no therapeutic options for people with severe COVID-19, the World Health Organization (WHO) recommended the use of a class of medicines called interleukin-6 antagonists on Tuesday. The medicines, tocilizumab and sarilumab, reduced the risk of death and ventilation when combined with corticosteroids, according to a study published the same day in […] Continue reading -> Forty New Medicines & 16 New Indications Under Consideration For WHO Essential Medicines List 21/06/2021 Elaine Ruth Fletcher Proposals to incorporate some 40 new medications in WHO’s Essential Medicines List – from complex cancer treatments to new medicines for hepatitis C and rabies – will be examined over the coming two weeks by the EML Expert Committee. The Committee, which kicked off its deliberations on Monday with a public hearing, also will consider […] Continue reading -> Technical Fixes or Sweeping Reform? Europe and Developing Countries Face Uphill Battle to Etch Consensus on IP Waiver 18/06/2021 Elaine Ruth Fletcher Proponents of a sweeping World Trade Organization ‘waiver’ on intellectual property rights for all COVID-19 treatments, tests and vaccines face an uphill battle to reach consensus on a text ahead of a WTO General Council meeting scheduled for 27-28 July. This is despite the recent agreement of the initiative’s opponents, including the European Union, Korea, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
REGEN-COV Joins COVID-19 Treatment List; WHO and MSF Call for Lower Prices and Increased Access 24/09/2021 Raisa Santos REGEN-COV, the antibody cocktail made famous by Donald Trump when he became ill with COVID in 2020, was added Friday to WHO’s list of recommended drug treatments in updated COVID-19 clinical management guidelines, published Friday. At the same time, WHO and Médecins Sans Frontières/Doctors Without Borders (MSF) called on the US pharma firm Regeneron, which […] Continue reading -> World Leaders Call on Future German Chancellor to Support TRIPS Waiver 15/09/2021 Kerry Cullinan More than 140 former heads of state and Nobel laureates have called on the three candidates in line to be the next German chancellor to declare themselves in favour of waiving intellectual property on COVID-19 vaccines and transferring vaccine technologies. Germany is leading the European Commission’s refusal to accept the so-called TRIPS waiver proposal put […] Continue reading -> ‘High Hopes’ of WTO Action to Curb Harmful Fisheries Subsidies & Stimulate Pandemic Response – But Decisions Punted to Autumn 27/07/2021 Elaine Ruth Fletcher World Trade Organization Director General Ngozi Okonjo-Iweala has ” high hopes” that the WTO Ministerial Conference (MC12) that convenes at the end of November can deliver decisions that curb harmful fisheries subsidies as well as improving access of low- and middle-income countries to COVID medicines and vaccines. But WTO members must overcome a series of […] Continue reading -> Access Advocates Urge 11th Hour WTO Action on COVID IP Waiver – COVAX Strikes World Bank Deal on Vaccine Finance 26/07/2021 Elaine Ruth Fletcher Vaccine access advocates issued increasingly desperate, last minute calls upon the World Trade Organization to take action over a stalled initiative to impose a temporary waiver on intellectual property for COVID medicines, tests and vaccines – even as the initiative appeared doomed to a stalemate for the rest of the summer. Ahead of the opening […] Continue reading -> China Has Failed to Share ‘Raw Data’ About Virus Origin so Lab Accident Can’t be Ruled Out, Says Tedros 15/07/2021 Kerry Cullinan China came under renewed pressure from the World Health Organization (WHO) and Germany on Thursday to share data it has so far withheld in order to help determine the origin of the SARS-CoV2 virus that has cost over four million lives. Conceding that China had not shared all the data that the WHO virus origins […] Continue reading -> Roche Suspends Patents on Tocilizumab in LMICs After WHO Recommends it as Treatment for Severe COVID-19 08/07/2021 Kerry Cullinan Swiss pharmaceutical company Roche has suspended its patent rights on the medication tocilizumab in low- and middle-income countries (LMICs) for the duration of the pandemic, the company announced Tuesday. This follows the World Health Organization (WHO) recommendation on Monday for interleukin-6 (IL-6) receptor blockers to be given to patients hospitalised with severe or critical […] Continue reading -> Finally, Therapeutics for Severe COVID-19 – But They Come With Hefty Price Tags 06/07/2021 Kerry Cullinan After months with virtually no therapeutic options for people with severe COVID-19, the World Health Organization (WHO) recommended the use of a class of medicines called interleukin-6 antagonists on Tuesday. The medicines, tocilizumab and sarilumab, reduced the risk of death and ventilation when combined with corticosteroids, according to a study published the same day in […] Continue reading -> Forty New Medicines & 16 New Indications Under Consideration For WHO Essential Medicines List 21/06/2021 Elaine Ruth Fletcher Proposals to incorporate some 40 new medications in WHO’s Essential Medicines List – from complex cancer treatments to new medicines for hepatitis C and rabies – will be examined over the coming two weeks by the EML Expert Committee. The Committee, which kicked off its deliberations on Monday with a public hearing, also will consider […] Continue reading -> Technical Fixes or Sweeping Reform? Europe and Developing Countries Face Uphill Battle to Etch Consensus on IP Waiver 18/06/2021 Elaine Ruth Fletcher Proponents of a sweeping World Trade Organization ‘waiver’ on intellectual property rights for all COVID-19 treatments, tests and vaccines face an uphill battle to reach consensus on a text ahead of a WTO General Council meeting scheduled for 27-28 July. This is despite the recent agreement of the initiative’s opponents, including the European Union, Korea, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
World Leaders Call on Future German Chancellor to Support TRIPS Waiver 15/09/2021 Kerry Cullinan More than 140 former heads of state and Nobel laureates have called on the three candidates in line to be the next German chancellor to declare themselves in favour of waiving intellectual property on COVID-19 vaccines and transferring vaccine technologies. Germany is leading the European Commission’s refusal to accept the so-called TRIPS waiver proposal put […] Continue reading -> ‘High Hopes’ of WTO Action to Curb Harmful Fisheries Subsidies & Stimulate Pandemic Response – But Decisions Punted to Autumn 27/07/2021 Elaine Ruth Fletcher World Trade Organization Director General Ngozi Okonjo-Iweala has ” high hopes” that the WTO Ministerial Conference (MC12) that convenes at the end of November can deliver decisions that curb harmful fisheries subsidies as well as improving access of low- and middle-income countries to COVID medicines and vaccines. But WTO members must overcome a series of […] Continue reading -> Access Advocates Urge 11th Hour WTO Action on COVID IP Waiver – COVAX Strikes World Bank Deal on Vaccine Finance 26/07/2021 Elaine Ruth Fletcher Vaccine access advocates issued increasingly desperate, last minute calls upon the World Trade Organization to take action over a stalled initiative to impose a temporary waiver on intellectual property for COVID medicines, tests and vaccines – even as the initiative appeared doomed to a stalemate for the rest of the summer. Ahead of the opening […] Continue reading -> China Has Failed to Share ‘Raw Data’ About Virus Origin so Lab Accident Can’t be Ruled Out, Says Tedros 15/07/2021 Kerry Cullinan China came under renewed pressure from the World Health Organization (WHO) and Germany on Thursday to share data it has so far withheld in order to help determine the origin of the SARS-CoV2 virus that has cost over four million lives. Conceding that China had not shared all the data that the WHO virus origins […] Continue reading -> Roche Suspends Patents on Tocilizumab in LMICs After WHO Recommends it as Treatment for Severe COVID-19 08/07/2021 Kerry Cullinan Swiss pharmaceutical company Roche has suspended its patent rights on the medication tocilizumab in low- and middle-income countries (LMICs) for the duration of the pandemic, the company announced Tuesday. This follows the World Health Organization (WHO) recommendation on Monday for interleukin-6 (IL-6) receptor blockers to be given to patients hospitalised with severe or critical […] Continue reading -> Finally, Therapeutics for Severe COVID-19 – But They Come With Hefty Price Tags 06/07/2021 Kerry Cullinan After months with virtually no therapeutic options for people with severe COVID-19, the World Health Organization (WHO) recommended the use of a class of medicines called interleukin-6 antagonists on Tuesday. The medicines, tocilizumab and sarilumab, reduced the risk of death and ventilation when combined with corticosteroids, according to a study published the same day in […] Continue reading -> Forty New Medicines & 16 New Indications Under Consideration For WHO Essential Medicines List 21/06/2021 Elaine Ruth Fletcher Proposals to incorporate some 40 new medications in WHO’s Essential Medicines List – from complex cancer treatments to new medicines for hepatitis C and rabies – will be examined over the coming two weeks by the EML Expert Committee. The Committee, which kicked off its deliberations on Monday with a public hearing, also will consider […] Continue reading -> Technical Fixes or Sweeping Reform? Europe and Developing Countries Face Uphill Battle to Etch Consensus on IP Waiver 18/06/2021 Elaine Ruth Fletcher Proponents of a sweeping World Trade Organization ‘waiver’ on intellectual property rights for all COVID-19 treatments, tests and vaccines face an uphill battle to reach consensus on a text ahead of a WTO General Council meeting scheduled for 27-28 July. This is despite the recent agreement of the initiative’s opponents, including the European Union, Korea, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
‘High Hopes’ of WTO Action to Curb Harmful Fisheries Subsidies & Stimulate Pandemic Response – But Decisions Punted to Autumn 27/07/2021 Elaine Ruth Fletcher World Trade Organization Director General Ngozi Okonjo-Iweala has ” high hopes” that the WTO Ministerial Conference (MC12) that convenes at the end of November can deliver decisions that curb harmful fisheries subsidies as well as improving access of low- and middle-income countries to COVID medicines and vaccines. But WTO members must overcome a series of […] Continue reading -> Access Advocates Urge 11th Hour WTO Action on COVID IP Waiver – COVAX Strikes World Bank Deal on Vaccine Finance 26/07/2021 Elaine Ruth Fletcher Vaccine access advocates issued increasingly desperate, last minute calls upon the World Trade Organization to take action over a stalled initiative to impose a temporary waiver on intellectual property for COVID medicines, tests and vaccines – even as the initiative appeared doomed to a stalemate for the rest of the summer. Ahead of the opening […] Continue reading -> China Has Failed to Share ‘Raw Data’ About Virus Origin so Lab Accident Can’t be Ruled Out, Says Tedros 15/07/2021 Kerry Cullinan China came under renewed pressure from the World Health Organization (WHO) and Germany on Thursday to share data it has so far withheld in order to help determine the origin of the SARS-CoV2 virus that has cost over four million lives. Conceding that China had not shared all the data that the WHO virus origins […] Continue reading -> Roche Suspends Patents on Tocilizumab in LMICs After WHO Recommends it as Treatment for Severe COVID-19 08/07/2021 Kerry Cullinan Swiss pharmaceutical company Roche has suspended its patent rights on the medication tocilizumab in low- and middle-income countries (LMICs) for the duration of the pandemic, the company announced Tuesday. This follows the World Health Organization (WHO) recommendation on Monday for interleukin-6 (IL-6) receptor blockers to be given to patients hospitalised with severe or critical […] Continue reading -> Finally, Therapeutics for Severe COVID-19 – But They Come With Hefty Price Tags 06/07/2021 Kerry Cullinan After months with virtually no therapeutic options for people with severe COVID-19, the World Health Organization (WHO) recommended the use of a class of medicines called interleukin-6 antagonists on Tuesday. The medicines, tocilizumab and sarilumab, reduced the risk of death and ventilation when combined with corticosteroids, according to a study published the same day in […] Continue reading -> Forty New Medicines & 16 New Indications Under Consideration For WHO Essential Medicines List 21/06/2021 Elaine Ruth Fletcher Proposals to incorporate some 40 new medications in WHO’s Essential Medicines List – from complex cancer treatments to new medicines for hepatitis C and rabies – will be examined over the coming two weeks by the EML Expert Committee. The Committee, which kicked off its deliberations on Monday with a public hearing, also will consider […] Continue reading -> Technical Fixes or Sweeping Reform? Europe and Developing Countries Face Uphill Battle to Etch Consensus on IP Waiver 18/06/2021 Elaine Ruth Fletcher Proponents of a sweeping World Trade Organization ‘waiver’ on intellectual property rights for all COVID-19 treatments, tests and vaccines face an uphill battle to reach consensus on a text ahead of a WTO General Council meeting scheduled for 27-28 July. This is despite the recent agreement of the initiative’s opponents, including the European Union, Korea, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Access Advocates Urge 11th Hour WTO Action on COVID IP Waiver – COVAX Strikes World Bank Deal on Vaccine Finance 26/07/2021 Elaine Ruth Fletcher Vaccine access advocates issued increasingly desperate, last minute calls upon the World Trade Organization to take action over a stalled initiative to impose a temporary waiver on intellectual property for COVID medicines, tests and vaccines – even as the initiative appeared doomed to a stalemate for the rest of the summer. Ahead of the opening […] Continue reading -> China Has Failed to Share ‘Raw Data’ About Virus Origin so Lab Accident Can’t be Ruled Out, Says Tedros 15/07/2021 Kerry Cullinan China came under renewed pressure from the World Health Organization (WHO) and Germany on Thursday to share data it has so far withheld in order to help determine the origin of the SARS-CoV2 virus that has cost over four million lives. Conceding that China had not shared all the data that the WHO virus origins […] Continue reading -> Roche Suspends Patents on Tocilizumab in LMICs After WHO Recommends it as Treatment for Severe COVID-19 08/07/2021 Kerry Cullinan Swiss pharmaceutical company Roche has suspended its patent rights on the medication tocilizumab in low- and middle-income countries (LMICs) for the duration of the pandemic, the company announced Tuesday. This follows the World Health Organization (WHO) recommendation on Monday for interleukin-6 (IL-6) receptor blockers to be given to patients hospitalised with severe or critical […] Continue reading -> Finally, Therapeutics for Severe COVID-19 – But They Come With Hefty Price Tags 06/07/2021 Kerry Cullinan After months with virtually no therapeutic options for people with severe COVID-19, the World Health Organization (WHO) recommended the use of a class of medicines called interleukin-6 antagonists on Tuesday. The medicines, tocilizumab and sarilumab, reduced the risk of death and ventilation when combined with corticosteroids, according to a study published the same day in […] Continue reading -> Forty New Medicines & 16 New Indications Under Consideration For WHO Essential Medicines List 21/06/2021 Elaine Ruth Fletcher Proposals to incorporate some 40 new medications in WHO’s Essential Medicines List – from complex cancer treatments to new medicines for hepatitis C and rabies – will be examined over the coming two weeks by the EML Expert Committee. The Committee, which kicked off its deliberations on Monday with a public hearing, also will consider […] Continue reading -> Technical Fixes or Sweeping Reform? Europe and Developing Countries Face Uphill Battle to Etch Consensus on IP Waiver 18/06/2021 Elaine Ruth Fletcher Proponents of a sweeping World Trade Organization ‘waiver’ on intellectual property rights for all COVID-19 treatments, tests and vaccines face an uphill battle to reach consensus on a text ahead of a WTO General Council meeting scheduled for 27-28 July. This is despite the recent agreement of the initiative’s opponents, including the European Union, Korea, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
China Has Failed to Share ‘Raw Data’ About Virus Origin so Lab Accident Can’t be Ruled Out, Says Tedros 15/07/2021 Kerry Cullinan China came under renewed pressure from the World Health Organization (WHO) and Germany on Thursday to share data it has so far withheld in order to help determine the origin of the SARS-CoV2 virus that has cost over four million lives. Conceding that China had not shared all the data that the WHO virus origins […] Continue reading -> Roche Suspends Patents on Tocilizumab in LMICs After WHO Recommends it as Treatment for Severe COVID-19 08/07/2021 Kerry Cullinan Swiss pharmaceutical company Roche has suspended its patent rights on the medication tocilizumab in low- and middle-income countries (LMICs) for the duration of the pandemic, the company announced Tuesday. This follows the World Health Organization (WHO) recommendation on Monday for interleukin-6 (IL-6) receptor blockers to be given to patients hospitalised with severe or critical […] Continue reading -> Finally, Therapeutics for Severe COVID-19 – But They Come With Hefty Price Tags 06/07/2021 Kerry Cullinan After months with virtually no therapeutic options for people with severe COVID-19, the World Health Organization (WHO) recommended the use of a class of medicines called interleukin-6 antagonists on Tuesday. The medicines, tocilizumab and sarilumab, reduced the risk of death and ventilation when combined with corticosteroids, according to a study published the same day in […] Continue reading -> Forty New Medicines & 16 New Indications Under Consideration For WHO Essential Medicines List 21/06/2021 Elaine Ruth Fletcher Proposals to incorporate some 40 new medications in WHO’s Essential Medicines List – from complex cancer treatments to new medicines for hepatitis C and rabies – will be examined over the coming two weeks by the EML Expert Committee. The Committee, which kicked off its deliberations on Monday with a public hearing, also will consider […] Continue reading -> Technical Fixes or Sweeping Reform? Europe and Developing Countries Face Uphill Battle to Etch Consensus on IP Waiver 18/06/2021 Elaine Ruth Fletcher Proponents of a sweeping World Trade Organization ‘waiver’ on intellectual property rights for all COVID-19 treatments, tests and vaccines face an uphill battle to reach consensus on a text ahead of a WTO General Council meeting scheduled for 27-28 July. This is despite the recent agreement of the initiative’s opponents, including the European Union, Korea, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Roche Suspends Patents on Tocilizumab in LMICs After WHO Recommends it as Treatment for Severe COVID-19 08/07/2021 Kerry Cullinan Swiss pharmaceutical company Roche has suspended its patent rights on the medication tocilizumab in low- and middle-income countries (LMICs) for the duration of the pandemic, the company announced Tuesday. This follows the World Health Organization (WHO) recommendation on Monday for interleukin-6 (IL-6) receptor blockers to be given to patients hospitalised with severe or critical […] Continue reading -> Finally, Therapeutics for Severe COVID-19 – But They Come With Hefty Price Tags 06/07/2021 Kerry Cullinan After months with virtually no therapeutic options for people with severe COVID-19, the World Health Organization (WHO) recommended the use of a class of medicines called interleukin-6 antagonists on Tuesday. The medicines, tocilizumab and sarilumab, reduced the risk of death and ventilation when combined with corticosteroids, according to a study published the same day in […] Continue reading -> Forty New Medicines & 16 New Indications Under Consideration For WHO Essential Medicines List 21/06/2021 Elaine Ruth Fletcher Proposals to incorporate some 40 new medications in WHO’s Essential Medicines List – from complex cancer treatments to new medicines for hepatitis C and rabies – will be examined over the coming two weeks by the EML Expert Committee. The Committee, which kicked off its deliberations on Monday with a public hearing, also will consider […] Continue reading -> Technical Fixes or Sweeping Reform? Europe and Developing Countries Face Uphill Battle to Etch Consensus on IP Waiver 18/06/2021 Elaine Ruth Fletcher Proponents of a sweeping World Trade Organization ‘waiver’ on intellectual property rights for all COVID-19 treatments, tests and vaccines face an uphill battle to reach consensus on a text ahead of a WTO General Council meeting scheduled for 27-28 July. This is despite the recent agreement of the initiative’s opponents, including the European Union, Korea, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Finally, Therapeutics for Severe COVID-19 – But They Come With Hefty Price Tags 06/07/2021 Kerry Cullinan After months with virtually no therapeutic options for people with severe COVID-19, the World Health Organization (WHO) recommended the use of a class of medicines called interleukin-6 antagonists on Tuesday. The medicines, tocilizumab and sarilumab, reduced the risk of death and ventilation when combined with corticosteroids, according to a study published the same day in […] Continue reading -> Forty New Medicines & 16 New Indications Under Consideration For WHO Essential Medicines List 21/06/2021 Elaine Ruth Fletcher Proposals to incorporate some 40 new medications in WHO’s Essential Medicines List – from complex cancer treatments to new medicines for hepatitis C and rabies – will be examined over the coming two weeks by the EML Expert Committee. The Committee, which kicked off its deliberations on Monday with a public hearing, also will consider […] Continue reading -> Technical Fixes or Sweeping Reform? Europe and Developing Countries Face Uphill Battle to Etch Consensus on IP Waiver 18/06/2021 Elaine Ruth Fletcher Proponents of a sweeping World Trade Organization ‘waiver’ on intellectual property rights for all COVID-19 treatments, tests and vaccines face an uphill battle to reach consensus on a text ahead of a WTO General Council meeting scheduled for 27-28 July. This is despite the recent agreement of the initiative’s opponents, including the European Union, Korea, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Forty New Medicines & 16 New Indications Under Consideration For WHO Essential Medicines List 21/06/2021 Elaine Ruth Fletcher Proposals to incorporate some 40 new medications in WHO’s Essential Medicines List – from complex cancer treatments to new medicines for hepatitis C and rabies – will be examined over the coming two weeks by the EML Expert Committee. The Committee, which kicked off its deliberations on Monday with a public hearing, also will consider […] Continue reading -> Technical Fixes or Sweeping Reform? Europe and Developing Countries Face Uphill Battle to Etch Consensus on IP Waiver 18/06/2021 Elaine Ruth Fletcher Proponents of a sweeping World Trade Organization ‘waiver’ on intellectual property rights for all COVID-19 treatments, tests and vaccines face an uphill battle to reach consensus on a text ahead of a WTO General Council meeting scheduled for 27-28 July. This is despite the recent agreement of the initiative’s opponents, including the European Union, Korea, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Technical Fixes or Sweeping Reform? Europe and Developing Countries Face Uphill Battle to Etch Consensus on IP Waiver 18/06/2021 Elaine Ruth Fletcher Proponents of a sweeping World Trade Organization ‘waiver’ on intellectual property rights for all COVID-19 treatments, tests and vaccines face an uphill battle to reach consensus on a text ahead of a WTO General Council meeting scheduled for 27-28 July. This is despite the recent agreement of the initiative’s opponents, including the European Union, Korea, […] Continue reading -> Posts navigation Older postsNewer posts